
Company valuation, historical trends, and peer comparisons.
According to Vivesto AB’s latest financial reports and current stock price. The company's current Enterprise Value is 38.57M. This represents a change of -99.41% compared to the average of 6.56B of the last 4 quarters.
The mean historical Enterprise Value of Vivesto AB over the last ten years is 73.33B. The current 38.57M Enterprise Value has changed -99.95% with respect to the historical average. Over the past ten years (40 quarters), OASMY's Enterprise Value was at its highest in in the April 2020 quarter at 336.84B. The Enterprise Value was at its lowest in in the June 2026 quarter at 92.32M.
Average
73.33B
Median
44.67B
Minimum
-40128000.00
Maximum
299.29B
Discovering the peaks and valleys of Vivesto AB Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 6.20%
Maximum Annual Enterprise Value = 299.29B
Minimum Annual Increase = -293187.04%
Minimum Annual Enterprise Value = -40128000.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 7.27B | -53.38% |
| 2024 | 15.60B | 6.20% |
| 2023 | 247.62M | -98.84% |
| 2022 | 21.40B | -81.80% |
| 2021 | 117.61B | -293187.04% |
| 2020 | -40128000.00 | -100.01% |
| 2020 | 299.29B | 147.79% |
| 2019 | 120.78B | 45.19% |
| 2018 | 83.19B | 22.45% |
| 2017 | 67.94B | -45.71% |
The current Enterprise Value of Vivesto AB (OASMY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.71B
5-year avg
32.43B
10-year avg
73.33B
Vivesto AB’s Enterprise Value is less than Valeo Pharma Inc. (57.68M), greater than China Health Industries Holdings, Inc. (5.11M), greater than BioQuest Corp. (7.86M), greater than Eco-Growth Strategies Inc. (11.14M), less than Medicure Inc. (41.44M), greater than Herbal Dispatch Inc. (4.36M), greater than Noveris Health Sciences Inc. (28.29M), greater than Rhelion Life Sciences Corp. (5.53M), less than OpGen, Inc. (88.57M), greater than Eagle Pharmaceuticals, Inc. (24.97M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 57.68M | $9.87K | |
| 5.11M | $6.55K | |
| 7.86M | $7.47M | |
| 11.14M | $4.28M | |
| 41.44M | $30.58M | |
| 4.36M | $2.00M | |
| 28.29M | $46.84M | |
| 5.53M | $8.90M | |
| 88.57M | $242.67M | |
| 24.97M | $12.50M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vivesto AB using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vivesto AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Vivesto AB's Enterprise Value?
What is the highest Enterprise Value for Vivesto AB (OASMY)?
What is the 3-year average Enterprise Value for Vivesto AB (OASMY)?
What is the 5-year average Enterprise Value for Vivesto AB (OASMY)?
How does the current Enterprise Value for Vivesto AB (OASMY) compare to its historical average?